Non-mRNA vaccine from Novavax, said to be better than Pfizer & Moderna, gets first approval in Indonesia

A Covid-19 vaccine from Novavax received its first emergency use authorization (EUA) from Indonesia, the company’s CEO, Stanley Erck, said on Monday (Nov 1). Approval for use is also expected within “weeks” in India, the Philippines and other countries, Novavax CEO Stanley Erck told Reuters.  More than five months ago, Singapore’s Health Minister Ong Ye … Continue reading Non-mRNA vaccine from Novavax, said to be better than Pfizer & Moderna, gets first approval in Indonesia